Zai Lab Ltd is a commercial-stage biopharmaceutical company with operations in Greater China and the United States, focused on oncology, immunology, neuroscience, and infectious disease. The company holds exclusive licenses from global partners to commercialize seven approved products in Greater China, including ZEJULA (niraparib) for ovarian cancer, VYVGART (efgartigimod) for myasthenia gravis, NUZYRA (omadacycline) for bacterial infections, OPTUNE (TTFields) for glioblastoma, QINLOCK (ripretinib) for GIST, XACDURO (sulbactam/durlobactam) for resistant pneumonia, and AUGTYRO (repotrectinib) for ROS1+ NSCLC. Zai Lab maintains an in-house R&D team and a commercial infrastructure covering medical affairs, marketing, and market access.
expected 2027-02-04
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-26 | 2025-12-31 | 0001704292-26-000015 | EDGAR | 87K words |
| 2025-02-27 | 2024-12-31 | 0001628280-25-008409 | EDGAR | 86K words |
| 2024-02-27 | 2023-12-31 | 0001628280-24-007235 | EDGAR | 86K words |
| 2023-03-01 | 2022-12-31 | 0001628280-23-005832 | EDGAR | 156K words |
| 2022-03-01 | 2021-12-31 | 0001193125-22-061312 | EDGAR | 160K words |
| 2021-03-01 | 2020-12-31 | 0001193125-21-062279 | EDGAR | 130K words |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-11-05 | 2026-09-30 | 0001628280-26-070521 | EDGAR | 18K words |
| 2026-08-06 | 2026-06-30 | 0001628280-26-053793 | EDGAR | 18K words |
| 2025-11-06 | 2025-09-30 | 0001704292-25-000024 | EDGAR | 18K words |
| 2025-08-07 | 2025-06-30 | 0001628280-25-038548 | EDGAR | 17K words |
| 2025-05-08 | 2025-03-31 | 0001628280-25-023411 | EDGAR | 16K words |
| 2024-11-12 | 2024-09-30 | 0001628280-24-046824 | EDGAR | 17K words |
| 2024-08-06 | 2024-06-30 | 0001628280-24-035231 | EDGAR | 17K words |
| 2024-05-08 | 2024-03-31 | 0001628280-24-021689 | EDGAR | 15K words |
| 2023-11-07 | 2023-09-30 | 0001628280-23-037358 | EDGAR | 22K words |
| 2023-08-07 | 2023-06-30 | 0001628280-23-027773 | EDGAR | 22K words |
| 2023-05-09 | 2023-03-31 | 0001628280-23-016816 | EDGAR | 19K words |
| 2022-11-09 | 2022-09-30 | 0001628280-22-029246 | EDGAR | 27K words |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-11-05 | 0001628280-26-070517 | EDGAR | 5K words |
| 2026-10-23 | 0001628280-26-066969 | EDGAR | 1K words |
| 2026-08-06 | 0001628280-26-053791 | EDGAR | 4K words |
| 2026-02-26 | 0001704292-26-000014 | EDGAR | 5K words |
| 2025-11-06 | 0001704292-25-000023 | EDGAR | 5K words |
| 2025-10-16 | 0001704292-25-000014 | EDGAR | 10K words |
| 2025-08-07 | 0001628280-25-038547 | EDGAR | 5K words |
| 2025-06-18 | 0001628280-25-032099 | EDGAR | 2K words |
| 2025-05-08 | 0001628280-25-023410 | EDGAR | 4K words |
| 2025-02-27 | 0001628280-25-008406 | EDGAR | 5K words |
168 total filings indexed. 140 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001704292 |
| Ticker | ZLAB |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | E9 |
| Website | https://www.zailaboratory.com |
| Listed | 2017-09-20 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/ZLAB (~200 tokens, structured JSON with cryptographic provenance)